NASDAQ:GRFS

Grifols Stock Predictions

Healthcare > Drug Manufacturers - General

Buy GRFS

*Your capital is at risk

$7.47

-0.160 (-2.10%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GRFS Prediction Chart

GRFS Predictions History

Latest community submissions for GRFS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 6, 2019	$19.43 +1.36%	$19.17	X	98.64%	1
NameNotImportant Pro	May 2, 2019	$20.30 +6.79%	$19.01	X	93.21%	0
NameNotImportant Pro	Apr 22, 2019	$18.75 +1.52%	$18.47	X	98.48%	0
JS Pro	Apr 27, 2016	$15.78 -0.88%	$15.92	X	99.10%	2

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GRFS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GRIFOLS

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by